High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial

DSpace Repository

High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial

Author: Hutchison, Colin A.; Cockwell, Paul; Moroz, Veronica; Bradwell, Arthur R.; Fifer, Lesley; Gillmore, Julian D.; Jesky, Mark D.; Storr, Markus; Wessels, Julie; Winearls, Christopher G.; Weisel, Katja; Heyne, Nils; Cook, Mark
Tübinger Autor(en):
Weisel, Katja
Heyne, Nils
Published in: Lancet Haematology (2019), Bd. 6, H. 4, S. E217-E228
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/S2352-3026(19)30014-6
ISSN: 2352-3026
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)